ASCO Abstract 2019
Personalized multimodality therapy with immune checkpoint inhibitors (ICI), chemotherapy (CT), and targeted treatment (TT) in advanced refractory cancer.
Category:
Developmental Immunotherapy and Tumor Immunobiology
Sub-category
Other IO-Related Topics
Meeting
2019 ASCO Annual Meeting
Details
Categories:
Created:
08 July 2019
Author:
Salem Oncology
Related
- Philip Salem Foundation Press Release ASCO Breakthrough August 2024
- El Covid-19 y los Derechos Humanos
- ICTriplex Presentation - Universidad de Guadalajara (2020)
- Advances in Cancer Medicine - El Occidental (2020)
- Combatting Cancer - Notisistema (2020)
- ICTriplex Treatment - Lider Informativo (2020)
- CIAM Presentation - Hospital Civil de Guadalajara (2020)
- Guadalajara Conference - El Informador (2020)
- Guadalajara Press Conference - Axópolis (2020)
- Guadalajara Press Conference - Mural (2020)